Myriad Genetics, Inc.MYGNNASDAQ
Loading
Debt to Equity Over TimeElevated
Percentile Rank100
3Y CAGR+51.6%
5Y CAGR+11.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+51.6%/yr
vs -6.5%/yr prior
5Y CAGR
+11.7%/yr
Recent acceleration
Acceleration
+58.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
4 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.57 | +184.9% |
| 2024 | 0.20 | +3.0% |
| 2023 | 0.19 | +18.6% |
| 2022 | 0.16 | +71.6% |
| 2021 | 0.10 | -70.9% |
| 2020 | 0.33 | +53.0% |
| 2019 | 0.21 | 0.0% |
| 2018 | 0.21 | +2124.8% |
| 2017 | 0.01 | -92.4% |
| 2016 | 0.13 | - |